{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T08:50:44Z","timestamp":1744707044725},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,24]],"date-time":"2010-04-24T00:00:00Z","timestamp":1272067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s12020-010-9341-5","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T15:26:12Z","timestamp":1272036372000},"page":"1-5","source":"Crossref","is-referenced-by-count":9,"title":["A case of fugitive acromegaly, initially presented as invasive prolactinoma"],"prefix":"10.1007","volume":"38","author":[{"given":"Jung Soo","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,24]]},"reference":[{"key":"9341_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1172-3-17","volume":"3","author":"P Chanson","year":"2008","unstructured":"P. Chanson, S. Salenave, Acromegaly. Orphanet J. Rare Dis. 3, 17 (2008)","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"9341_CR2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1507\/endocrj.K07E-055","volume":"55","author":"A Avramidis","year":"2008","unstructured":"A. Avramidis, S.A. Polyzos, Z. Efstathiadou, M. Kita, Sustained clinical inactivity and stabilization of GH\/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatment. Endocr. J. 55(2), 351\u2013357 (2008)","journal-title":"Endocr. J."},{"issue":"4","key":"9341_CR3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L","volume":"47","author":"E Horvath","year":"1981","unstructured":"E. Horvath, K. Kovacs, W. Singer, H.S. Smyth, D.W. Killinger, C. Erzin, M.H. Weiss, Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases. Cancer 47(4), 761\u2013771 (1981)","journal-title":"Cancer"},{"issue":"2","key":"9341_CR4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"W. Saeger, D.K. Ludecke, M. Buchfelder, R. Fahlbusch, H.J. Quabbe, S. Petersenn, Pathohistological classification of pituitary tumors: 10\u00a0years of experience with the German Pituitary Tumor Registry. Eur. J. Endocrinol. 156(2), 203\u2013216 (2007)","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"9341_CR5","first-page":"3409","volume":"85","author":"HG Maheshwari","year":"2000","unstructured":"H.G. Maheshwari, T.R. Prezant, V. Herman-Bonert, H. Shahinian, K. Kovacs, S. Melmed, Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma. J. Clin. Endocrinol. Metab. 85(9), 3409\u20133416 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"9341_CR6","first-page":"68","volume":"75","author":"SL Asa","year":"1992","unstructured":"S.L. Asa, K. Kovacs, E. Horvath, W. Singer, H.S. Smyth, Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line. J. Clin. Endocrinol. Metab. 75(1), 68\u201375 (1992)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"9341_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1026225625897","volume":"6","author":"ME Molitch","year":"2003","unstructured":"M.E. Molitch, Dopamine resistance of prolactinomas. Pituitary 6(1), 19\u201327 (2003)","journal-title":"Pituitary"},{"issue":"3","key":"9341_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1017\/S0317167100021892","volume":"24","author":"G Mohr","year":"1997","unstructured":"G. Mohr, Z.P. Chen, M. Schweitzer, Acromegaly with normal basal growth hormone levels. Can. J. Neurol. Sci. 24(3), 250\u2013253 (1997)","journal-title":"Can. J. Neurol. Sci."},{"issue":"10","key":"9341_CR9","first-page":"3419","volume":"83","author":"B Swearingen","year":"1998","unstructured":"B. Swearingen, F.G. Barker 2nd, L. Katznelson, B.M. Biller, S. Grinspoon, A. Klibanski, N. Moayeri, P.M. Black, N.T. Zervas, Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 83(10), 3419\u20133426 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"21","key":"9341_CR10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJM197911223012102","volume":"301","author":"DR Clemmons","year":"1979","unstructured":"D.R. Clemmons, J.J. Van Wyk, E.C. Ridgway, B. Kliman, R.N. Kjellberg, L.E. Underwood, Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N. Engl. J. Med. 301(21), 1138\u20131142 (1979)","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"9341_CR11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/eje.1.02112","volume":"154","author":"A Colao","year":"2006","unstructured":"A. Colao, R. Pivonello, R.S. Auriemma, M.C. De Martino, M. Bidlingmaier, F. Briganti, F. Tortora, P. Burman, I.A. Kourides, C.J. Strasburger, G. Lombardi, Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur. J. Endocrinol. 154(3), 467\u2013477 (2006)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"9341_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2265.2008.03469.x","volume":"71","author":"CE Higham","year":"2009","unstructured":"C.E. Higham, T.T. Chung, J. Lawrance, W.M. Drake, P.J. Trainer, Long-term experience of pegvisomant therapy as a treatment for acromegaly. Clin Endocrinol (Oxf) 71(1), 86\u201391 (2009)","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"9341_CR13","first-page":"87","volume":"48","author":"M Gradiser","year":"2007","unstructured":"M. Gradiser, M. Matovinovic, M. Vrkljan, Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly. Croat. Med. J. 48(1), 87\u201391 (2007)","journal-title":"Croat. Med. J."},{"issue":"9","key":"9341_CR14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI200316575","volume":"111","author":"AP Heaney","year":"2003","unstructured":"A.P. Heaney, M. Fernando, S. Melmed, PPAR-gamma receptor ligands: novel therapy for pituitary adenomas. J. Clin. Invest. 111(9), 1381\u20131388 (2003)","journal-title":"J. Clin. Invest."},{"issue":"2","key":"9341_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1009903603495","volume":"1","author":"GJ Kaptain","year":"1999","unstructured":"G.J. Kaptain, N.E. Simmons, T.D. Alden, M.B. Lopes, M.L. Vance, E.R. Laws, Estrogen receptors in prolactinomas: a clinico-pathological study. Pituitary 1(2), 91\u201398 (1999)","journal-title":"Pituitary"},{"issue":"3","key":"9341_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11102-008-0154-y","volume":"12","author":"SW Lamberts","year":"2009","unstructured":"S.W. Lamberts, L.J. Hofland, Future treatment strategies of aggressive pituitary tumors. Pituitary 12(3), 261\u2013264 (2009)","journal-title":"Pituitary"},{"issue":"1","key":"9341_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000217826","volume":"14","author":"B Caronti","year":"1993","unstructured":"B. Caronti, G. Palladini, M.G. Bevilacqua, E. Petrangeli, B. Fraioli, G. Cantore, G. Tamburrano, C.M. Carapella, M.L. Jaffrain-Rea, Effects of 17 beta-estradiol, progesterone and tamoxifen on in vitro proliferation of human pituitary adenomas: correlation with specific cellular receptors. Tumour Biol. 14(1), 59\u201368 (1993)","journal-title":"Tumour Biol."},{"issue":"3","key":"9341_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14310\/horm.2002.11155","volume":"4","author":"I Vourliotaki","year":"2005","unstructured":"I. Vourliotaki, I.E. Bonapart, C. Stamataki, E.M. Tsapakis, C. Saridaki, A case of a prolactinoma resistant to dopamine agonists. Hormones (Athens) 4(3), 165\u2013170 (2005)","journal-title":"Hormones (Athens)"},{"issue":"15","key":"9341_CR19","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1158\/0008-5472.CAN-08-0508","volume":"68","author":"G Vlotides","year":"2008","unstructured":"G. Vlotides, E. Siegel, I. Donangelo, S. Gutman, S.G. Ren, S. Melmed, Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands. Cancer Res. 68(15), 6377\u20136386 (2008)","journal-title":"Cancer Res."},{"issue":"8","key":"9341_CR20","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/ijc.24884","volume":"126","author":"E Gutteridge","year":"2010","unstructured":"E. Gutteridge, A. Agrawal, R. Nicholson, K.L. Cheung, J. Robertson, J. Gee, The effects of gefitinib in tamoxifen resistant and hormone insensitive breast cancer: a phase II study. Int. J. Cancer. 126(8), 1806\u20131816 (2010)","journal-title":"Int. J. Cancer."},{"issue":"1","key":"9341_CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1507\/endocrj.49.41","volume":"49","author":"K Kageyama","year":"2002","unstructured":"K. Kageyama, T. Nigawara, Y. Kamata, T. Takahashi, J. Anzai, S. Suzuki, Y.R. Osamura, T. Suda, A case of macroprolactinoma with subclinical growth hormone production. Endocr. J. 49(1), 41\u201347 (2002)","journal-title":"Endocr. J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-010-9341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-010-9341-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-010-9341-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:56:26Z","timestamp":1559426186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-010-9341-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,24]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["9341"],"URL":"https:\/\/doi.org\/10.1007\/s12020-010-9341-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,24]]}}}